Surgery Partners, Inc.SGRY

NasdaqHealthcareServices-General Medical & Surgical Hospitals, NEC
Price (close)
$14.20
Market cap
$1.9B
P/E
—
Revenue (TTM)
$3.4B
Net income
-$88.6M
Dividend yield
—
1-year total return
-34.2%
Net margin
-2.6%
Revenue growth
4.0%
Debt / equity
2.25x

What Surgery Partners, Inc. does.

Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."

We are a leading healthcare services company with an integrated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. We are one of the largest and fastest growing surgical services businesses in the United States ("U.S."), with more than 200 locations in 30 states, including ambulatory surgery centers ("ASCs"), short-stay surgical hospitals ("surgical hospitals"), and multi-specialty physician practices, among others. Patient services provided in our ASCs and surgical hospitals (collectively, "surgical facilities" or "facilities") generated approximately $3.2 billion in revenue during 2025.

Our differentiated operating model employs a multifaceted strategy to grow revenue, earnings and cash flow. We believe the following are key components to this strategy:

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$1.9B$2.2B$2.5B$2.7B$3.1B$3.3B
Net income-$116.1M-$70.9M-$54.6M-$11.9M-$168.1M-$77.9M
Free cash flow$204.0M$29.5M$78.2M$205.0M$209.7M$195.6M

More on SGRY.

Figures from Surgery Partners, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.